Search For "pharma"
Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment of moder
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India.
Read More
Moderna to supply twice as many than planned COVID vaccine doses in 2022
Updated : 4 years, 10 months ago IST
New York [US], April 29 (ANI/Sputnik): US pharmaceutical company Moderna seeks to supply 3 billion vaccine doses against COVID-19 in 2022 instead of 1.4 billion, which is twice as many than planned, according to the company's statement, published on Thursday.
Read More
ISSAR Pharma announces out-licensing of its Peptide-based NCEs
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], April 29 (ANI/PNN): ISSAR Pharmaceuticals, pioneers in Peptide Technology and peptide drug innovation, has decided to license out their peptide-based New Chemical Entities (NCEs), with pre-IND filing and US patent.
Read More
COVID-19: Russian flights with emergency humanitarian aid land in India
Updated : 4 years, 10 months ago IST
New Delhi [India], April 29 (ANI): Two Russian flights with oxygen concentrators, lung ventilation equipment, bedside monitors, medicines, including Coronavir and other essential pharmaceutical items landed in India to help the country in its fight against the COVID-19 surge.
Read More
Fire breaks out at pharma company in Maharashtra's Ratnagiri
Updated : 4 years, 10 months ago IST
Ratnagiri (Maharashtra) [India], April 28 (ANI): A major fire broke out at a pharmaceutical company, MR Pharma, in Maharashtra's Ratnagiri on Wednesday.
Read More
Morepen seals Rs 750 crore investment from Corinth Group of Switzerland
Updated : 4 years, 10 months ago IST
New Delhi [India], April 28 (ANI): The board of directors at Morepen Laboratories Ltd on Wednesday approved the investment proposed by Corinth Group, a global private investment firm headquartered in Switzerland, to the extent of 100 million dollars (about Rs 750 crore).
Read More
MHA exempts three sectors from limitations on using liquid oxygen for medi
Updated : 4 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Ministry of Home Affairs on Monday exempted the ampules and vials industry, pharmaceutical industry and defence forces from limitations on using liquid oxygen exclusively for medical purposes.
Read More
Sensex climbs 508 points, banking stocks surge
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], Apr 26 (ANI): Equity benchmark indices remained bullish despite trimming some early gains on Monday following some reports that India's second wave of coronavirus will peak soon.
Read More
Anihac Pharma to launch gainer Whey Protein in chocolate flavour
Updated : 4 years, 10 months ago IST
New Delhi [India], April 26 (ANI/The PRTree): India's one of the most reputed health and nutritional supplement brands, Anihac Pharma, is set to launch gainer whey protein in chocolate flavor. With manufacturing units all over India, largest being in Uttrakhand, the company's trademark has b
Read More
ACG wins prestigious iF Design Award 2021
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 26 (ANI/PRNewswire): Judged out of Hamburg in Germany, iF awards recognise products from around the world that exhibit superior innovation and exemplary design.
Read More
Glenmark's Ryaltris® nasal spray now approved in Europe for the first
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 coun
Read More
Optimus Pharma launched a new Anti-Parkinson's Drug in India
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI/PNN): Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off
Read More